On the public citation graph

Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovines

https://doi.org/10.1101/2021.07.26.453840
0 signed · 53 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/rmv.2231openalex-snapshot
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
inferredcites →https://doi.org/10.1007/s15010-020-01548-8openalex-snapshot
Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg
inferredcites →https://doi.org/10.1016/j.bbrc.2020.10.109openalex-snapshot
The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design
inferredcites →https://doi.org/10.1016/j.chom.2021.02.020openalex-snapshot
The variant gambit: COVID-19’s next move
inferredcites →https://doi.org/10.1016/j.xcrm.2021.100255openalex-snapshot
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
inferredcites →https://doi.org/10.1016/s2213-2600(21)00005-9openalex-snapshot
New variant of SARS-CoV-2 in UK causes surge of COVID-19
inferredcites →https://doi.org/10.1038/nbt.1521openalex-snapshot
Antigen-specific human polyclonal antibodies from hyperimmunized cattle
inferredcites →https://doi.org/10.1038/s41541-020-00279-zopenalex-snapshot
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
inferredcites →https://doi.org/10.1038/s41577-021-00542-xopenalex-snapshot
Neutralizing monoclonal antibodies for treatment of COVID-19
inferredcites →https://doi.org/10.1038/s41577-021-00544-9openalex-snapshot
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
inferredcites →https://doi.org/10.1038/s41579-020-00459-7openalex-snapshot
Characteristics of SARS-CoV-2 and COVID-19
inferredcites →https://doi.org/10.1038/s41586-020-2895-3openalex-snapshot
Spike mutation D614G alters SARS-CoV-2 fitness
inferredcites →https://doi.org/10.1038/s41586-021-03291-yopenalex-snapshot
SARS-CoV-2 evolution during treatment of chronic infection
inferredcites →https://doi.org/10.1038/s41591-021-01255-3openalex-snapshot
Sixteen novel lineages of SARS-CoV-2 in South Africa
inferredcites →https://doi.org/10.1038/s41598-020-72528-zopenalex-snapshot
Structural and functional modelling of SARS-CoV-2 entry in animal models
inferredcites →https://doi.org/10.1073/pnas.2010146117openalex-snapshot
Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates
inferredcites →https://doi.org/10.1080/14737159.2021.1917998openalex-snapshot
The importance of genomic analysis in cracking the coronavirus pandemic
inferredcites →https://doi.org/10.1080/21645515.2021.1940652openalex-snapshot
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
inferredcites →https://doi.org/10.1093/infdis/jiy377openalex-snapshot
Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate
inferredcites →https://doi.org/10.1099/jgv.0.001481openalex-snapshot
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients
inferredcites →https://doi.org/10.1099/jgv.0.001584openalex-snapshot
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
inferredcites →https://doi.org/10.1126/sciadv.abh0319openalex-snapshot
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses
inferredcites →https://doi.org/10.1126/science.abc6952openalex-snapshot
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
inferredcites →https://doi.org/10.1126/science.abe8499openalex-snapshot
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
inferredcites →https://doi.org/10.1126/science.abf6950openalex-snapshot
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
inferredcites →https://doi.org/10.1126/scitranslmed.aaf1061openalex-snapshot
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
inferredcites →https://doi.org/10.1128/jvi.00226-17openalex-snapshot
Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus
inferredcites →https://doi.org/10.1128/jvi.02012-06openalex-snapshot
Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus
inferredcites →https://doi.org/10.1371/journal.pone.0090383openalex-snapshot
Triple Immunoglobulin Gene Knockout Transchromosomic Cattle: Bovine Lambda Cluster Deletion and Its Effect on Fully Human Polyclonal Antibody Production
inferredcites →https://doi.org/10.1371/journal.pone.0130699openalex-snapshot
Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle
inferredcites →https://doi.org/10.1371/journal.ppat.1008903openalex-snapshot
SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts
inferredcites →https://doi.org/10.2139/ssrn.3725763openalex-snapshot
Landscape Analysis of Escape Variants Identifies SARS-CoV-2 Spike Mutations that Attenuate Monoclonal and Serum Antibody Neutralization
inferredcites →https://doi.org/10.3390/vaccines9030243openalex-snapshot
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
inferredcites →https://doi.org/10.7150/ijbs.47827openalex-snapshot
SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations
inferredcites →https://doi.org/10.7554/elife.61312openalex-snapshot
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/jmv.27907openalex-snapshot
Transchromosomic bovines‐derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS‐CoV‐2, MERS‐CoV, Ebola, Zika, HIV‐1, and influenza A virus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2023.105605openalex-snapshot
Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models
inferred← citeshttps://doi.org/10.1016/j.ijsu.2022.106233openalex-snapshot
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
inferred← citeshttps://doi.org/10.1038/s41467-023-37059-xopenalex-snapshot
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
inferred← citeshttps://doi.org/10.1038/s41586-022-04441-6openalex-snapshot
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
inferred← citeshttps://doi.org/10.1038/s41586-022-04856-1openalex-snapshot
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
inferred← citeshttps://doi.org/10.1038/s41586-022-05482-7openalex-snapshot
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
inferred← citeshttps://doi.org/10.1101/2023.08.19.553970openalex-snapshot
No evidence for enhanced disease with polyclonal SARS-CoV-2 antibody in the ferret model
inferred← citeshttps://doi.org/10.1126/scitranslmed.ado2104openalex-snapshot
Animal models of Long Covid: A hit-and-run disease
inferred← citeshttps://doi.org/10.1128/mbio.02906-21openalex-snapshot
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2
inferred← citeshttps://doi.org/10.1186/s12985-021-01633-wopenalex-snapshot
Evolutionary trajectory of SARS-CoV-2 and emerging variants
inferred← citeshttps://doi.org/10.1186/s13568-022-01355-4openalex-snapshot
Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus
inferred← citeshttps://doi.org/10.1371/journal.pone.0290909openalex-snapshot
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model
inferred← citeshttps://doi.org/10.1590/0074-02760220239openalex-snapshot
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries
inferred← citeshttps://doi.org/10.3389/fcimb.2021.792584openalex-snapshot
Experimental Models of COVID-19
inferred← citeshttps://doi.org/10.3389/fimmu.2021.761250openalex-snapshot
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
inferred← citeshttps://doi.org/10.3390/antib12020033openalex-snapshot
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
inferred← citeshttps://doi.org/10.47488/dhrp.v1is5.31openalex-snapshot
Is There Any Advantage of Using Polyclonal vs. Monoclonal Antibodies for Passive Enhancement of Immunity in Patients with COVID-19?
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.